SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $104,000 | -69.7% | 1,341 | -70.9% | 0.00% | -50.0% |
| Q1 2021 | $343,000 | -27.8% | 4,606 | +65.1% | 0.00% | -33.3% |
| Q4 2020 | $475,000 | -34.4% | 2,789 | -45.9% | 0.00% | -40.0% |
| Q3 2020 | $724,000 | -7.5% | 5,158 | +5.6% | 0.01% | 0.0% |
| Q2 2020 | $783,000 | +866.7% | 4,886 | +491.5% | 0.01% | +400.0% |
| Q1 2020 | $81,000 | +636.4% | 826 | +1080.0% | 0.00% | – |
| Q2 2019 | $11,000 | +37.5% | 70 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | 0.0% | 70 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -27.3% | 70 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | -54.2% | 70 | -88.6% | 0.00% | – |
| Q4 2015 | $24,000 | -84.0% | 614 | -86.8% | 0.00% | -100.0% |
| Q3 2015 | $150,000 | -68.4% | 4,657 | -70.1% | 0.00% | -50.0% |
| Q2 2015 | $474,000 | – | 15,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |